XIAP inhibits caspase‐3 and ‐7 using two binding sites: evolutionarily conserved mechanism of IAPs
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372
X-linked IAP is a direct inhibitor of cell-death proteases
Deveraux, Q. L., Takahashi, R., Salvesen, G. S., & Reed, J. C. (1997) · Nature · doi:10.1038/40901 · Cited by 1,955
Self-citationIAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756 · cited 1×
“These include the mammalian IAP antagonists Smac/DIABLO and HtrA2, and the Drosophila Hid, Grim and Reaper proteins (reviewed in Salvesen and Duckett, 2002; Vaux and Silke, 2003).”
BackgroundSelf-citationCaspase structure, proteolytic substrates, and function during apoptotic cell death
Nicholson, D. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400598 · Cited by 1,543
Srinivasula, S. M., Hegde, R., Saleh, A., Datta, P., Shiozaki, E., Chai, J., Lee, R.-A., Robbins, P. D., Fernandes-Alnemri, T., Shi, Y., et al. (2001) · Nature · doi:10.1038/35065125 · Cited by 1,013
Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M., & Ashwell, J. D. (2000) · Science · doi:10.1126/science.288.5467.874 · Cited by 988
Structural and biochemical basis of apoptotic activation by Smac/DIABLO
Chai, J., Du, C., Wu, J.-W., Kyin, S., Wang, X., & Shi, Y. (2000) · Nature · doi:10.1038/35022514 · Cited by 864
Structural Basis for the Inhibition of Caspase-3 by XIAP
Riedl, S. J., Renatus, M., Schwarzenbacher, R., Zhou, Q., Sun, C., Fesik, S. W., Liddington, R. C., & Salvesen, G. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00274-4 · Cited by 792
Self-citationDeveraux, Q. L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5242 · Cited by 751
Cited by
Targeting IAP proteins for therapeutic intervention in cancer
Fulda, S., & Vucic, D. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3627 · Cited by 837
“The peptide-binding groove on the surface of the BIR2 domain of XIAP also makes important interactions with the N termini of the small subunits of partially processed caspase 3 and caspase 7 (Ref”
BackgroundJulien, O., & Wells, J. A. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.44 · Cited by 816
“include the E3 ligase X chromosome-linked inhibitor of apoptosis protein.(94) Other E3 ligases may facilitate caspase”
BackgroundHuman inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Eckelman, B. P., Salvesen, G. S., & Scott, F. L. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400795 · Cited by 813
Self-citationIAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer
Gyrd-Hansen, M., & Meier, P. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2889 · Cited by 790
“Nevertheless, the BIR2 domain is functionally important as it makes additional contact with an IBM motif present at the neo-amino-terminus of the caspase subuni”
BackgroundIAPs, RINGs and ubiquitylation
Vaux, D. L., & Silke, J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1621 · Cited by 610
The inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565
“many BIR domains including BIR2 and BIR3 of XIAP and BIR1 and BIR2 of DIAP1, a functional orthologue in Drosophila melanogaster [88, 89].”
BackgroundRegulation of the Apaf-1–caspase-9 apoptosome
Bratton, S. B., & Salvesen, G. S. (2010) · Journal of Cell Science · doi:10.1242/jcs.073643 · Cited by 433
Self-citationThe Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases
Eckelman, B. P., & Salvesen, G. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510863200 · Cited by 391
Self-citationSurvivin and IAP proteins in cell-death mechanisms
Altieri, D. C. (2010) · Biochemical Journal · doi:10.1042/bj20100814 · Cited by 376
Timmer, J. C., & Salvesen, G. S. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402059 · Cited by 376
Self-citationTargeting XIAP for the treatment of malignancy
Schimmer, A. D., Dalili, S., Batey, R. A., & Riedl, S. J. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401826 · Cited by 304
Self-citationXIAP mediates NOD signaling via interaction with RIP2
Krieg, A., Correa, R. G., Garrison, J. B., Le Negrate, G., Welsh, K., Huang, Z., Knoefel, W. T., & Reed, J. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907131106 · Cited by 286
The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer
Vucic, D., & Fairbrother, W. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0729 · Cited by 206
Biological and clinical roles of IL-18 in inflammatory diseases
Landy, E., Carol, H., Ring, A., & Canna, S. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-01053-w · Cited by 197
“The spectrum of manifestations in XIAP deficiency is broad, but includes HLH, inflammatory bowel disease, skin manifestations, uveitis and hypogammaglobulinaemia 190,191 (Fig.”
Knight, T., Luedtke, D., Edwards, H., Taub, J. W., & Ge, Y. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.015 · Cited by 169
A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis
Walters, J., Pop, C., Scott, F. L., Drag, M., Swartz, P., Mattos, C., Salvesen, G. S., & Clark, A. C. (2009) · Biochemical Journal · doi:10.1042/bj20090825 · Cited by 160
Self-citationReeve, J. L. V., Duffy, A. M., O'Brien, T., & Samali, A. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00492.x · Cited by 113
“The presence of, cytoplasmic caspase inhibitory molecules, IAPs, also obstruct the function of active caspases -3, -7 and 9 through direct interaction [55–58].”
BackgroundInhibition of BMI1 induces autophagy-mediated necroptosis
Dey, A., Mustafi, S. B., Saha, S., Kumar Dhar Dwivedi, S., Mukherjee, P., & Bhattacharya, R. (2016) · Autophagy · doi:10.1080/15548627.2016.1147670 · Cited by 97
“downregulated, we think due to induction of XIAP which inhibits caspase activity.(30,44,45) In OvCa cells, PTC-209 did not induce apoptosis as determined by several assays such as”
BackgroundChessari, G., Buck, I. M., Day, J. E. H., Day, P. J., Iqbal, A., Johnson, C. N., Lewis, E. J., Martins, V., Miller, D., Reader, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00706 · Cited by 90
Tamanini, E., Buck, I. M., Chessari, G., Chiarparin, E., Day, J. E. H., Frederickson, M., Griffiths-Jones, C. M., Hearn, K., Heightman, T. D., Iqbal, A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01877 · Cited by 72
Jinesh G., G., Chunduru, S., & Kamat, A. M. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1211623 · Cited by 60
“However, XIAP, a known inhibitor of active caspases [27], was down-regulated by the combination of Smac mimetic and BCG-stimulated neutrophil conditioned medium (Fig.”
Taniguchi, M., Ogiso, H., Takeuchi, T., Kitatani, K., Umehara, H., & Okazaki, T. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.82 · Cited by 57
Structures of BIRC6-client complexes provide a mechanism of SMAC-mediated release of caspases
Hunkeler, M., Jin, C. Y., & Fischer, E. S. (2023) · Science · doi:10.1126/science.ade5750 · Cited by 48
Connolly, K., Mitter, R., Muir, M., Jodrell, D., & Guichard, S. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0872-x · Cited by 34
“The main function of XIAP is inhibition of executioner caspases 3 and 7 [ 3 ] and initiator caspase 9 [4], and XIAP is the only member of the family to inhibit both phases of the cascade directly [5].”
BackgroundTherapeutics Targeting the Core Apoptotic Machinery
Hamilton, C., Fox, J. P., Longley, D. B., & Higgins, C. A. (2021) · Cancers · doi:10.3390/cancers13112618 · Cited by 26
“Several mechanisms of acquired resistance to IAP antagonists have been described including the upregulation of cIAP2 which initially is degraded along with cIAP1 but can rebound as cIAP1 acts as an E3 Ligase for cIAP2, so in the absence of cIAP1, it is stabilized [98,127] (Table 1).”
BackgroundInfluentialPal, A., Sengupta, S., & Kundu, R. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113686 · Cited by 18
Structure shows that the BIR2 domain of E3 ligase XIAP binds across the RIPK2 kinase dimer interface
Lethier, M., Huard, K., Hons, M., Favier, A., Brutscher, B., Boeri Erba, E., Abbott, D. W., Cusack, S., & Pellegrini, E. (2023) · Life Science Alliance · doi:10.26508/lsa.202201784 · Cited by 11
Metadata
- Authors
- Scott, F. L., Denault, J., Riedl, S. J., Shin, H., Renatus, M., & Salvesen, G. S.
- Venue
- The EMBO Journal
- Published
- 2005-01-13
- Volume
- 24
- Issue
- 3
- Pages
- 645-655
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W1976935037
- Cited by
- 421
- References
- 42
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.